Unknown

Dataset Information

0

Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer.


ABSTRACT: Agents targeting the PD1-PDL1 axis have transformed cancer therapy. Factors that influence clinical response to PD1-PDL1 inhibitors include tumor mutational burden, immune infiltration of the tumor, and local PDL1 expression. To identify peripheral correlates of the anti-tumor immune response in the absence of checkpoint blockade, we performed a retrospective study of circulating T cell subpopulations and matched tumor gene expression in melanoma and non-small cell lung cancer (NSCLC) patients. Notably, both melanoma and NSCLC patients whose tumors exhibited increased inflammatory gene transcripts presented high CD4+ and CD8+ central memory T cell (CM) to effector T cell (Eff) ratios in blood. Consequently, we evaluated CM/Eff T cell ratios in a second cohort of NSCLC. The data showed that high CM/Eff T cell ratios correlated with increased tumor PDL1 expression. Furthermore, of the 22 patients within this NSCLC cohort who received nivolumab, those with high CM/Eff T cell ratios, had longer progression-free survival (PFS) (median survival: 91 vs. 215?days). These findings show that by providing a window into the state of the immune system, peripheral T cell subpopulations inform about the state of the anti-tumor immune response and identify potential blood biomarkers of clinical response to checkpoint inhibitors in melanoma and NSCLC.

SUBMITTER: Manjarrez-Orduno N 

PROVIDER: S-EPMC6085412 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications


Agents targeting the PD1-PDL1 axis have transformed cancer therapy. Factors that influence clinical response to PD1-PDL1 inhibitors include tumor mutational burden, immune infiltration of the tumor, and local PDL1 expression. To identify peripheral correlates of the anti-tumor immune response in the absence of checkpoint blockade, we performed a retrospective study of circulating T cell subpopulations and matched tumor gene expression in melanoma and non-small cell lung cancer (NSCLC) patients.  ...[more]

Similar Datasets

| S-EPMC8885413 | biostudies-literature
| S-EPMC4504811 | biostudies-literature
| S-EPMC6911635 | biostudies-literature
| S-EPMC10097753 | biostudies-literature
| S-EPMC8428355 | biostudies-literature
| S-EPMC3719570 | biostudies-literature
| S-EPMC10278479 | biostudies-literature
| S-EPMC6727487 | biostudies-literature
| S-EPMC6879872 | biostudies-literature
| S-EPMC8508335 | biostudies-literature